LATINALLIANCE OPENS NEW OFFICES AT HONDURAS

At LatinAlliance we are pleased to announce the opening of our offices in Tegucigalpa, Honduras. Consistent with our commitment to always provide the best service, and responding to the needs that have moved us previously, we are expanding and will open, this 25th of April, our own offices in Honduras. We trust that this news… Read more »

LATINALLIANCE INTRODUCES LIFE SCIENCES – THEIR RENEWED PRACTICE AREA

Throughout the 26 years of our history, at LatinAlliance we have become a regional reference in the Product Regulation practice area. Since the beginning, the Product Regulation area has advised multinational companies in the registration process of their products belonging to the pharmaceutical, food and beverages, medical devices, cosmetic and veterinary industries. The growth this… Read more »

“Characteristics of the International Arbitration” – our head of the Dispute Resolution: Litigation and Arbitration departmente, Herbert Guerrero, attended this presentation

On February 22, our Dispute Resolution: Prevention, Litigation and Arbitration director, Herbert Guerrero, attended the presentation “Particularidades del Arbitraje Internacional – International Arbitration Characteristics”, organized by the Spanish Arbitration Club and delivered by Dr. Javier Navarro, partner at Baker McKenzie in Mexico and Director of the  Litigation and Arbitration department. The conference addressed matters such… Read more »

“EL ENCANTO” – A WORLD-CLASS GOLF COURSE IN CENTRAL AMERICA

One of our most emblematic clients in the practice areas of Banking & Finance and Tourism is definitely “El Encanto Villa & Golf”, a Real Estate project in which the team of LatinAlliance provided legal assistance in syndicated fiduciary loan matters. These types of projects are a clear sign of development in El Salvador, and… Read more »

GlaxoSmithKline and Pfizer, leader companies in the pharmaceutical business, will combine to create a joint venture

19 December, 2018 – The British pharmaceutical company, GlaxoSmithKline (GSK) and the American pharmaceutical company, Pfizer, announced the union of their Consumer Healthcare areas to create a joint venture that will allow them to become the largest company in consumer healthcare with sells up to $12.7 billion dollars. With this transaction both companies will become… Read more »